![Western Blot: ZNHIT2 Antibody [NBP2-88755] - Host: Rabbit. Target Name: ZNHIT2. Sample Type: Fetal Stomach lysates. Antibody Dilution: 1.0ug/ml](http://images.novusbio.com/fullsize/ZNHIT2-Antibody-Western-Blot-NBP2-88755-img0001.jpg "Western Blot: ZNHIT2 Antibody [NBP2-88755] - Host: Rabbit. Target Name: ZNHIT2. Sample Type: Fetal Stomach lysates. Antibody Dilution: 1.0ug/ml")
| Reactivity | HuSpecies Glossary |
| Applications | WB |
| Clonality | Polyclonal |
| Host | Rabbit |
| Conjugate | Unconjugated |
| Format | BSA Free |
| Concentration | 0.5 mg/ml |
| Description | Novus Biologicals Rabbit ZNHIT2 Antibody - BSA Free (NBP2-88755) is a polyclonal antibody validated for use in WB. All Novus Biologicals antibodies are covered by our 100% guarantee. |
| Immunogen | The immunogen is a synthetic peptide directed towards the C-terminal region of Human ZNHIT2. Peptide sequence: KGYTLAALGDLAQTLGRARKQAVAREERDHLYRARKKCQFLLAWTNENEA The peptide sequence for this immunogen was taken from within the described region. |
| Clonality | Polyclonal |
| Host | Rabbit |
| Gene | ZNHIT2 |
| Purity | Affinity purified |
| Innovator's Reward | Test in a species/application not listed above to receive a full credit towards a future purchase. |
| Storage | Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles. |
| Buffer | PBS, 2% Sucrose |
| Preservative | 0.09% Sodium Azide |
| Concentration | 0.5 mg/ml |
| Purity | Affinity purified |
Secondary Antibodies |
Isotype Controls |
The concentration calculator allows you to quickly calculate the volume, mass or concentration of your vial. Simply enter your mass, volume, or concentration values for your reagent and the calculator will determine the rest.
| Gene Symbol | ZNHIT2 |
![Immunocytochemistry FUBI/MNSF beta/FAU Antibody (861504) [Unconjugated]](https://images.novusbio.com/images2/FUBI_MAB9036_Immunocytochemistry__Immunofluorescence_19164.jpg)
![Western Blot FUBI/MNSF beta/FAU Antibody (861504) [Unconjugated]](https://images.novusbio.com/images2/FUBI_MAB9036_Western_Blot_19167.jpg)
![Immunocytochemistry Goosecoid Antibody [Unconjugated]](https://images.novusbio.com/images2/Goosecoid_AF4086_Immunocytochemistry__Immunofluorescence_20128.jpg)
![Bioactivity Sonic Hedgehog/Shh [Unconjugated]](https://images.novusbio.com/images2/Sonic_Hedgehog_464SH_2840.jpg)
![SDS-PAGE Sonic Hedgehog/Shh [Unconjugated]](https://images.novusbio.com/images2/Sonic_Hedgehog_464-SH_341.jpg)
![SEC-MALS Sonic Hedgehog/Shh [Unconjugated]](https://images.novusbio.com/images/464-sh_recombinant-mouse-sonic-hedgehog-shh-c25ii-n-terminus-sec-mals-642023224324.jpg)
![Flow Cytometry TGF-beta RIII Antibody [Unconjugated]](https://images.novusbio.com/images2/TGF-beta_RIII_AF-242-PB_Flow_Cytometry_3386.jpg)
![Immunohistochemistry TGF-beta RIII Antibody [Unconjugated]](https://images.novusbio.com/images2/TGFbeta_RIII_AF242PB_Immunohistochemistry_24178.jpg)
![Flow Cytometry TGF-beta RIII Antibody [Unconjugated]](https://images.novusbio.com/images2/af-242-pb_human-tgf-beta-riii-affinity-purified-polyclonal-ab-flow-cytometry-276202216543.jpg)
![Western Blot TGF-beta RI/ALK-5 Antibody [Unconjugated]](https://images.novusbio.com/images2/TGFbeta_RI_AF3025_Western_Blot_17081.jpg)
![Immunocytochemistry TGF-beta RI/ALK-5 Antibody [Unconjugated]](https://images.novusbio.com/images2/TGF-beta_RI_AF3025_Immunocytochemistry_9948.jpg)
![Western Blot TGF-beta RI/ALK-5 Antibody [Unconjugated]](https://images.novusbio.com/images/af3025_human-tgf-beta-ri-alk-5-affinity-purified-polyclonal-ab-41202412402510.jpg)
![SDS-PAGE TGF-beta 2 [Unconjugated]](https://images.novusbio.com/images2/TGF-beta_2_302-B2_268.jpg)
![Bioactivity TGF-beta 2 [Unconjugated]](https://images.novusbio.com/images2/TGF-beta_2_302-B2_269.jpg)
![Surface Plasmon Resonance (SPR) TGF-beta 2 [Unconjugated]](https://images.novusbio.com/images/302-b2_recombinant-human-tgf-beta-2-protein-surface-plasmon-resonance-spr-144202585019..jpg)
![Western Blot: Goat anti-Rabbit IgG (H+L) Secondary Antibody [HRP] [NB7160] - Western blot showing vemurafenib treatment in BRAFV600E CRC cells inhibits fission mediator DRP1 with no significant effect on fusion proteins (Mfn1 & 2) using MFN-1 antibody (NBP1-51841) and corresponding secondary antibody, goat anti-rabbit IgG-HRP (NB7160). Image collected and cropped by CiteAb from the following publication (https://pubmed.ncbi.nlm.nih.gov/33738242).](https://images.novusbio.com/images/Goat-anti-Rabbit-IgG-H+L-Secondary-Antibody-HRP-Western-Blot-NB7160-img0001.jpg "Western Blot: Goat anti-Rabbit IgG (H+L) Secondary Antibody [HRP] [NB7160] - Western blot showing vemurafenib treatment in BRAFV600E CRC cells inhibits fission mediator DRP1 with no significant effect on fusion proteins (Mfn1 & 2) using MFN-1 antibody (NBP1-51841) and corresponding secondary antibody, goat anti-rabbit IgG-HRP (NB7160). Image collected and cropped by CiteAb from the following publication (https://pubmed.ncbi.nlm.nih.gov/33738242).")
